Beta-galactosidase-tagged adventitial myofibroblasts tracked to the neointima in healing rat vein grafts

Journal of Vascular Research

Volumn 40, Issue 3, 2003, Pages 266-275

  Tomas, Jeffrey J ^a   Stark, V Emily ^a   Kim, Jimmy L ^a   Wolff, Randal A ^a   Hullett, Debra A ^a   Warner, Thomas F ^a   Hoch, John R ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adventitia; Intimal hyperplasia; Myofibroblast; Neointima; Vein graft; Wound healing

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL WALL; CELL DEATH; CELL MIGRATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENETIC CODE; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VEIN GRAFT; WOUND HEALING;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CELL DIVISION; CELL MOVEMENT; CONNECTIVE TISSUE CELLS; CYTOSKELETAL PROTEINS; FEMORAL ARTERY; FIBROBLASTS; GENETIC VECTORS; HYPERPLASIA; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED LEW; TRANSFECTION; TUNICA INTIMA; VEINS; WOUND HEALING;

EID: 0042573993     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071890     Document Type: Article

References (35)

1. Davies MG, Hagen P-O: Pathobiology of intimal hyperplasia. Br J Surg 1994;81:1254-1269.
2. Mills JL: Mechanisms of vein graft failure: The location, distribution, and characteristics of lesions that predispose to graft failure. Semin Vasc Surg 1993;6:78-91.
3. Herrman JPR, Hermans WRM, Vos J, Serruys PW: Pharmacological approaches to the prevention of restenosis following angioplasty: The search for the Holy Grail? (Part II). Drugs 1993;45:249-262.
4. Bennett MR, O'Sullivan M: Mechanisms of angioplasty and stent restenosis: Implications for design of rational therapy. Pharmacol Ther 2001;91:149-166.
5. Sternberg SS: Histology for Pathologists. New York, Raven, 1992.
6. Desmouliere A, Gabbiani G: Modulation of fibroblastic cytoskeletal features during pathological situations: The role of extracellular matrix and cytokines. Cell Motil Cytoskeleton 1994;29:195-203.
7. Shi Y, O'Brien JE, Fard A, Zalewski A: Transforming growth factor-beta1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 1996;16:1298-1305.
8. Darby I, Skalli O, Gabbiani G: Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-29.
9. Schurch W, Seemayer TA, Gabbiani G: Myofibroblast; in Sternberg SS (ed): Histology for Pathologists. New York, Raven, 1992, pp 109-144.
10. Eyden B: The myofibroblast: An assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol 2001;25:39-50.
11. Stark VK, Warner TF, Hoch JR: An ultrastructural study of progressive intimal hyperplasia in rat vein grafts. J Vasc Surg 1997;26:94-103.
12. Kalra M, Miller VM: Early remodeling of saphenous vein grafts: Proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. J Vasc Res 2000;37: 576-584.
13. Wilcox JN, Waksman R, King SB, Scott NA: The role of the adventitia in the arterial response to angioplasty: The effect of intravascular radiation. Int J Radiat Oncol Biol Phys 1996;36:789-796.
14. Shi Y, O'Brien E, Fard A, Mannion JD, Wang D, Zalewski A: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996;94: 1655-1664.
15. O'Brien JE Jr, Shi Y, Fard A, Bauer T, Zalewski A, Mannion JD: Wound healing around and within saphenous vein bypass grafts. J Thorac Cardiovasc Surg 1997;114:38-45.
16. Hoch JR, Stark VK, Hullett DA, Turnipseed WD: Vein graft intimal hyperplasia: Leukocytes and cytokine gene expression. Surgery 1994;116:463-471.
17. Institute of Laboratory Animal Resources (US): Guide for the Care and Use of Laboratory Animals. Washington, National Academy, 1996.
18. Hoch JR, Stark VK, Turnipseed WD: The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression. J Vasc Surg 1995;22:51-58.
19. Stark VK, Hoch JR, Warner TF, Hullett DA: Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. Arterioscler Thromb Vasc Biol 1997;17:1614-1621.
20. Green JA, Edqards RE, Manson MM: Immunohistochemical detection of bromodeoxyuridine-labeled nuclei for in vivo cell kinetic studies; in Manson MM (ed): Immunochemical Protocols. Totowa, Humana, 1992, vol 10, pp 131-135.
21. Coursin DB, Cihla HP, Oberley TD, Oberley LW: Immunolocalization of antioxidant enzymes and isozymes of glutathione S-transferase in normal rat lung. Am J Physiol 1992;263: L679-L691.
22. Becker TC, BeltrandelRio H, Noel RJ, Johnson JH, Newgard CB: Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J Biol Chem 1994;269:21234-21238.
23. Schwartz SM, DeBlois D, O'Brien ERM: The intima. Soil for atherosclerosis and restenosis. Circ Res 1995;77:445-465.
24. Kockx MM, Cambier BA, Bortier HE, De Meyer GR, Van Cauwelaert PA: The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts. Virchows Arch A Pathol Anat Histopathol 1992;420:155-162.
25. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A: Adventitial remodeling after coronary arterial injury. Circulation 1996; 93:340-348.
26. Staab ME, Srivatsa SS, Lerman S, Sangiorgi G, Jeong MH, Edwards WD, Holmes DR Jr, Schwartz RS: Arterial remodeling after experimental percutaneous injury is highly dependent on adventitial injury and histopathology. Int J Cardiol 1997;58:31-40.
27. Kovacs EJ, Van Stedum S, Neuman JE: Selective induction of PDGF gene expression in peritoneal macrophages by interleukin-2. Immunobiology 1994;190:263-274.
28. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB: Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-6024.
29. Schmitt-Graff A, Desmouliere A, Gabbiani G: Heterogeneity of myofibroblast phenotypic features: An example of fibroblastic cell plasticity. Virchows Arch 1994;425:3-24.
30. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
31. Hoch JR, Stark VK: Apoptosis in vein graft intimal hyperplasia. Surg Forum 1996;47:384-387.
32. Shi Y, O'Brien JE Jr, Mannion JD, Morrison RC, Chung W, Fard A, Zalewski A: Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 1997;95:2684-2693.
33. Hu Y, Mayr M, Metzler B, Erdel M, Davison F, Xu Q: Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res 2002;91:e13-e20.
34. Li G, Chen SJ, Oparil S, Chen YF, Thompson JA: Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 2000;101:1362-1365.
35. de Leon H, Ollerenshaw JD, Griendling KK, Wilcox JN: Adventitial cells do not contribute to neointimal mass after balloon angioplasty of the rat common carotid artery. Circulation 2001;104:1591-1593.